Human breast tumor cells are more resistant to cardiac glycoside toxicity than non-tumorigenic breast cells.
Cardiotonic steroids (CTS), specific inhibitors of Na,K-ATPase activity, have been widely used for treating cardiac insufficiency. Recent studies suggest that low levels of endogenous CTS do not inhibit Na,K-ATPase activity but play a role in regulating blood pressure, inducing cellular kinase activ...
Main Authors: | Rebecca J Clifford, Jack H Kaplan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3862803?pdf=render |
Similar Items
-
FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells.
by: Sungeun Kim, et al.
Published: (2013-01-01) -
The role of cardiac glycosides in influencing breast cancer cell proliferation
by: Quinlan KD, et al.
Published: (2012-07-01) -
Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity
by: Claudia Koch, et al.
Published: (2020-09-01) -
EBV enhances tumorigenic activity in human breast cancer cells
by: Jiun-Han Lin, et al.
Published: (2007) -
Differential anti-cancer signaling exerted by an in silico-designed compound in tumorigenic and non-tumorigenic breast cells
by: Visagie, M.H. (Michelle Helen)
Published: (2014)